FBR-22237-64889
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 232 / VA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
-
2021-02-25
Survey response — day 21, dose 2MedDRA: Body temperature increased, Cough, Fatigue — Feeling: GoodFree text: Feb 20th - Slightly elevated temp (<100 F) and extreme fatigue all day. No cough during the day, but have experienced intermittent coughing during sleep since that day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-08
- 2021-08-05
-
2021-10-03
Dose 3 — Pfizer-BioNTech
- 2021-10-03
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, NauseaFree text: Swollen lymph glands on same side as injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body achesFree text: Swollen lymph glandsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-10-09
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-02
- 2022-04-03
-
2022-10-03
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, COVID-19, Chest pain, Chills, Cough, Dyspnoea, Fatigue, Myalgia, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I contracted COVID the last week of July 2022. I had fever, chills, cough, muscle aches, fatigue, loss of smell and taste, chest pain, and shortness of breath. Acute symptoms lasted 14 days. I'm still dealing with shortness of breath and chest pains.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-05
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — day 21, dose 2
Symptoms: Feb 20th - Slightly elevated temp (<100 F) and extreme fatigue all day. No cough during the day, but have experienced intermittent coughing during sleep since that day.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph glands on same side as injection site
Systemic reaction (other): Swollen lymph glands
Release 12 — 12 months, dose 3
Symptoms: I contracted COVID the last week of July 2022. I had fever, chills, cough, muscle aches, fatigue, loss of smell and taste, chest pain, and shortness of breath. Acute symptoms lasted 14 days. I'm still dealing with shortness of breath and chest pains. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Body temperature increased | ✓ | ✓ | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release